Derived neutrophil to lymphocyte ratio predicts prognosis for patients with HBV-associated hepatocellular carcinoma following transarterial chemoembolization.
about
Clinical Predictors for Neutrophil-to-Lymphocyte Ratio Changes in Patients with Chronic Hepatitis B Receiving Peginterferon Treatment.Neutrophil-lymphocyte Ratio Plus Prognostic Nutritional Index Predicts the Outcomes of Patients with Unresectable Hepatocellular Carcinoma After Transarterial Chemoembolization.Neutrophil-to-lymphocyte and aspartate-to-alanine aminotransferase ratios predict hepatocellular carcinoma prognosis after transarterial embolization.A novel combined systemic inflammation-based score can predict survival of intermediate-to-advanced hepatocellular carcinoma patients undergoing transarterial chemoembolization.
P2860
Derived neutrophil to lymphocyte ratio predicts prognosis for patients with HBV-associated hepatocellular carcinoma following transarterial chemoembolization.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Derived neutrophil to lymphocy ...... ansarterial chemoembolization.
@en
type
label
Derived neutrophil to lymphocy ...... ansarterial chemoembolization.
@en
prefLabel
Derived neutrophil to lymphocy ...... ansarterial chemoembolization.
@en
P2093
P2860
P356
P1433
P1476
Derived neutrophil to lymphocy ...... ransarterial chemoembolization
@en
P2093
Dongsheng Zhou
Fengying He
Jianzhong Liang
Minshan Chen
Zhongguo Zhou
P2860
P304
P356
10.3892/OL.2016.4359
P50
P577
2016-03-21T00:00:00Z